Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Aquinox Pharmaceuticals Inc    AQXP

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/09/2018 01/10/2018 01/11/2018 01/12/2018 01/16/2018 Date
11.51(c) 11.54(c) 11.65(c) 11.51(c) 11.47 Last
42 872 52 750 66 402 29 122 74 039 Volume
-1.71% +0.26% +0.95% -1.20% -0.35% Change
More quotes
Financials ($)
Sales 2017 -
EBIT 2017 -49,2 M
Net income 2017 -47,9 M
Finance 2017 108 M
Yield 2017 -
Sales 2018 2,50 M
EBIT 2018 -59,4 M
Net income 2018 -55,3 M
Finance 2018 148 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 0
EV / Sales2018 49,0x
Capitalization 270 M
More Financials
Company
Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company.It discovers and develops targeted therapeutics for inflammation and immuno-oncology.The company's primary focus is on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular... 
Sector
Pharmaceuticals
Calendar
03/19Earnings Release
More about the company
Surperformance© ratings of Aquinox Pharmaceuticals In
Trading Rating : Investor Rating : -
More Ratings
Latest news on AQUINOX PHARMACEUTICALS IN
01/08 AQUINOX PHARMACEUTICALS, INC : Regulation FD Disclosure, Financial Statements an..
2017 AQUINOX PHARMACEUTICALS : Promotes Lloyd Mackenzie to Chief Operating Officer an..
2017 BIOCENTURY - MANAGEMENT TRACKS : Chugai, bioMerieux
2017 AQUINOX PHARMACEUTICALS, INC. (NASDA : AQXP) Files An 8-K Departure of Directors..
2017 AQUINOX PHARMACEUTICALS, INC : Change in Directors or Principal Officers (form 8..
2017 Aquinox Promotes Lloyd Mackenzie to Chief Operating Officer and Vice Presiden..
2017 Aquinox Statement on FDA Advisory Committee Meeting to Discuss Interstitial C..
2017 AQUINOX PHARMACEUTICALS : to Participate in 29th Annual Piper Jaffray Healthcare..
2017 Aquinox to Participate in 29th Annual Piper Jaffray Healthcare Conference
2017 AQUINOX PHARMACEUTICALS : Announces Third Quarter 2017 Financial Results
More news
Sector news : Pharmaceuticals - NEC
01/15 Drugmaker Dermapharm gears up for likely first German IPO of 2018
01/12 Drugmakers see a pricing blueprint in an $850,000 gene therapy
01/12 SPARK'S PRICE FOR LUXTURNA BLINDNESS : Icer
01/12 ASTRAZENECA : Receives FDA Approval for Breast Cancer Treatment
01/12 WPP Buys London-based Mash Strategy
More sector news : Pharmaceuticals - NEC
Latest Tweets
01/14Zacks Investment Research Downgrades Aquinox Pharmaceuticals $AQXP to Hold  
01/07How Hitler could solve our housing crisis | David Mitchell
17
01/07How Hitler could solve our housing crisis | David Mitchell
26
01/07How Hitler could solve our housing crisis | David Mitchell
1
01/07How Hitler could solve our housing crisis | David Mitchell  
More tweets
Qtime:144
News from SeekingAlpha
2017 YOUR DAILY PHARMA SCOOP : Synergy's New CEO, AbbVie Data, TiGenix Changes
2017 YOUR DAILY PHARMA SCOOP : Omeros Potential, Portola's Setback, Proteostasis Soar..
2017 Aquinox Pharma up 16% premarket on FDA advisory committee vote on IC/BPS stud..
2017 BIOTECH FORUM DAILY DIGEST : Revisiting Neos Therapeutics
2017 NASDAQ BIOTECH INDEX : 54 to be added, 15 removed
Chart AQUINOX PHARMACEUTICALS IN
Duration : Period :
Aquinox Pharmaceuticals In Technical Analysis Chart | AQXP | US03842B1017 | 4-Traders
Technical analysis trends AQUINOX PHARMACEUTICALS IN
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 24,3 $
Spread / Average Target 111%
EPS Revisions
Managers
NameTitle
David J. Main Chairman, President & Chief Executive Officer
Lloyd Mackenzie Chief Operating Officer
Kamran Alam Chief Financial Officer, Secretary & VP
David Green Vice President-Global Clinical Operations
Barbara Troupin Chief Medical Officer & VP-Clinical Development
Sector and Competitors
1st jan.Capitalization (M$)
AQUINOX PHARMACEUTICALS INC-2.13%270
JOHNSON & JOHNSON4.32%388 981
NOVARTIS1.80%224 968
PFIZER0.88%217 923
ROCHE HOLDING LTD.-0.28%217 905
MERCK AND COMPANY4.25%159 987